Long-term Follow-up of Participants Treated With Galapagos Chimeric Antigen Receptor (CAR) T-cell Therapies

NCT06652633 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

546

Enrollment

INDUSTRY

Sponsor class

Conditions

Hematological Malignancies

Interventions

GENETIC: GLPG CAR T-cell therapy

Sponsor

Lakefront Biotherapeutics NV